{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T13:44:02Z","timestamp":1786196642143,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023993","name":"North Carolina Collaboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.josat.2026.210052","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:05:20Z","timestamp":1781798720000},"page":"210052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Methadone in community pharmacies: A mixed methods study of board-certified addiction medicine physician and addiction psychiatrist perspectives"],"prefix":"10.1016","volume":"190","author":[{"given":"Grace T.","family":"Marley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Shubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ava","family":"Nunnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delesha","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210052_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2022.208946","article-title":"Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore","volume":"145","author":"Abidogun","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"7\u20138","key":"10.1016\/j.josat.2026.210052_bb0010","first-page":"8","article-title":"Methadone treatment of opiate addiction: A systematic review of comparative studies","volume":"14","author":"Ali","year":"2017","journal-title":"Innovations in Clinical Neuroscience"},{"issue":"9","key":"10.1016\/j.josat.2026.210052_bb0015","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1093\/aje\/kwaf092","article-title":"Investigating heterogeneous effects of an expanded methadone access policy with opioid treatment program retention: A Rhode Island population-based retrospective cohort study","volume":"194","author":"Allen","year":"2025","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.josat.2026.210052_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsat.2018.07.006","article-title":"Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington","volume":"93","author":"Amiri","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00952990.2019.1620261","article-title":"Spatial access to opioid treatment program and alcohol and cannabis outlets: Analysis of missed doses of methadone during the first, second, and third 90 days of treatment","volume":"46","author":"Amiri","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.210052_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108727","article-title":"Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment","volume":"224","author":"Amiri","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value in Health"},{"key":"10.1016\/j.josat.2026.210052_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104924","article-title":"\u201cStigma is our most powerful enemy\u201d: Understanding opioid use disorder stigma and the role of peer support in rural Maryland","volume":"143","author":"Anvari","year":"2025","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2026.210052_bb0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention","volume":"25","author":"Beardsley","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.josat.2026.210052_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2026.210052_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/appi.ajp.20220312","article-title":"Risk of experiencing an overdose event for patients undergoing treatment with medication for opioid use disorder","volume":"180","author":"Brandt","year":"2023","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2026.210052_bb0060","series-title":"Thematic analysis: A practical guide","author":"Braun","year":"2021"},{"issue":"5","key":"10.1016\/j.josat.2026.210052_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177388","article-title":"Stigma of addiction and mental illness in healthcare: The case of patients\u2019 experiences in dental settings","volume":"12","author":"Brondani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2026.210052_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100067","article-title":"Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability","volume":"3","author":"Brooner","year":"2022","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"10.1016\/j.josat.2026.210052_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2026.210052_bb0080","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: What the United States can learn from the global effort to treat opioid addiction","volume":"34","author":"Calcaterra","year":"2019","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2026.210052_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100138","article-title":"Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone","volume":"6","author":"Carl","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ADM.0000000000001244","article-title":"A brief online training to address pharmacists\u2019 willingness to dispense buprenorphine","volume":"18","author":"Carpenter","year":"2024","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210052_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001742","article-title":"Community pharmacist perspectives on methadone services: A cross-sectional survey study","author":"Carpenter","year":"2026","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210052_bb0100","series-title":"July 12","author":"CDC","year":"2025"},{"key":"10.1016\/j.josat.2026.210052_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2026.210052_bb0110","series-title":"Qualitative inquiry and research design: Choosing among five approaches","author":"Creswell","year":"2013"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11414-018-9616-9","article-title":"Overcoming barriers to adopting and implementing pharmacotherapy: The medication research partnership","volume":"46","author":"Croff","year":"2019","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2026.210052_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2022.100154","article-title":"A content review of buprenorphine training programs for pharmacists","volume":"6","author":"Davis","year":"2022","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.josat.2026.210052_bb0130","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural and Remote Health"},{"key":"10.1016\/j.josat.2026.210052_bb0135","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"12","key":"10.1016\/j.josat.2026.210052_bb0140","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/0193945920914647","article-title":"Integration through connecting in explanatory sequential mixed method studies","volume":"42","author":"Draucker","year":"2020","journal-title":"Western Journal of Nursing Research"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11469-012-9402-5","article-title":"Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma","volume":"11","author":"Earnshaw","year":"2013","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\u201cIt\u2019s like \u201cliquid handcuffs\u201d: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u201d lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.210052_bb0155","series-title":"Stigma: Notes on the management of spoiled identity","author":"Goffman","year":"2022"},{"key":"10.1016\/j.josat.2026.210052_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/SAR.S183256","article-title":"Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders","volume":"9","author":"Hammarlund","year":"2018","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"6","key":"10.1016\/j.josat.2026.210052_bb0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: Institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.josat.2026.210052_bb0170","article-title":"Methadone take-home policies and associated mortality: Permitting versus non-permitting states","volume":"18","author":"Harris","year":"2024","journal-title":"Substance Use: Research and Treatment"},{"key":"10.1016\/j.josat.2026.210052_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2025.100339","article-title":"Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses","volume":"15","author":"Harris","year":"2025","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"5","key":"10.1016\/j.josat.2026.210052_bb0180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.sapharm.2020.06.024","article-title":"Methods and strategies for effectively surveying the LGBTQ+ population","volume":"17","author":"Hughes","year":"2021","journal-title":"Research in Social & Administrative Pharmacy: RSAP"},{"key":"10.1016\/j.josat.2026.210052_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","author":"Hunter","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210052_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/21501319251359547","article-title":"Use of pharmacists and collaborative practice agreements to treat hepatitis c: A survey of primary care clinicians in Washington State","volume":"16","author":"James","year":"2025","journal-title":"Journal of Primary Care & Community Health"},{"issue":"9","key":"10.1016\/j.josat.2026.210052_bb0195","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the us before and after federal policy changes expanding take-home methadone doses from opioid treatment programs","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2026.210052_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ADM.0000000000000950","article-title":"Office-based methadone prescribing for opioid use disorder: The Canadian model","volume":"16","author":"Kleinman","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210052_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2017.08.002","article-title":"Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support","volume":"180","author":"Kulesza","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210052_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12884-021-03596-w","article-title":"\u201cThe elephant in the room;\u201d a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia","volume":"21","author":"Leiner","year":"2021","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0215","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/08897077.2021.1986768","article-title":"COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership","volume":"43","author":"Levander","year":"2022","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/29767342231215178","article-title":"Relationships between stigma, risk tolerance, and buprenorphine dispensing intentions among community-based pharmacists: results from a national sample","volume":"45","author":"Light","year":"2024","journal-title":"Substance Use & Addiction Journal"},{"key":"10.1016\/j.josat.2026.210052_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2024.100898","article-title":"Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: A serial cross-sectional analysis","volume":"39","author":"Lim","year":"2024","journal-title":"Lancet Regional Health. Americas"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10826084.2017.1325376","article-title":"Primary care physicians\u2019 views about prescribing methadone to treat opioid use disorder","volume":"53","author":"Livingston","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"9","key":"10.1016\/j.josat.2026.210052_bb0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25538","article-title":"Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island","volume":"4","author":"Macmadu","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210052_bb0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Social Science & Medicine (1982)"},{"key":"10.1016\/j.josat.2026.210052_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109100","article-title":"Treatment provider perceptions of take-home methadone regulation before and during COVID-19","volume":"228","author":"Madden","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"14","key":"10.1016\/j.josat.2026.210052_bb0250","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention stigma toward medications for opioid use disorder: A systematic review","volume":"56","author":"Madden","year":"2021","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2026.210052_bb0255","article-title":"Factors in rural community buprenorphine dispensing","volume":"9","author":"Major","year":"2022","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.josat.2026.210052_bb0260","author":"Markey"},{"key":"10.1016\/j.josat.2026.210052_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2026.103472","article-title":"Pharmacists\u2019 perceptions on pharmacy-based methadone treatment for opioid use disorder: a semi-structured interview study","author":"Marley","year":"2026","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/j.josat.2026.210052_bb0270","author":"National Institute on Drug Abuse"},{"issue":"21","key":"10.1016\/j.josat.2026.210052_bb0275","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.2024.16954","article-title":"Buprenorphine\/naloxone vs methadone for the treatment of opioid use disorder","volume":"332","author":"Nosyk","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2026.210052_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826084.2026.2670621","article-title":"\u201cMethadone at the pharmacy like Suboxone\u00ae?... It would untangle a lot of tangles.\u201d \u2013 Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies","author":"Ostrach","year":"2026","journal-title":"Substance Use & Misuse"},{"issue":"2015","key":"10.1016\/j.josat.2026.210052_bb0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-soc-071312-145702","article-title":"The stigma complex","volume":"41","author":"Pescosolido","year":"2015","journal-title":"Annual Review of Sociology"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102319","article-title":"Community pharmacy-based buprenorphine programs and pharmacists\u2019 roles, knowledge, attitudes, and barriers to providing buprenorphine-related services: A systematic review","volume":"65","author":"Rawal","year":"2025","journal-title":"Journal of the American Pharmacists Association: JAPhA"},{"key":"10.1016\/j.josat.2026.210052_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104381","article-title":"Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis","volume":"126","author":"Roy","year":"2024","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2026.210052_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2026.209942","article-title":"Perspectives from opioid treatment program staff on community pharmacy-based methadone dispensing in North Carolina","author":"Shubel","year":"2026","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210052_bb0305","doi-asserted-by":"crossref","DOI":"10.1177\/29767342261449037","article-title":"Expanding methadone access through community pharmacies: a qualitative study exploring opioid treatment program staff perceptions of pharmacy-based medication units","author":"Shubel","year":"2026","journal-title":"Substance Use & Addiction Journal"},{"issue":"S2","key":"10.1016\/j.josat.2026.210052_bb0310","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","article-title":"The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists","volume":"112","author":"Simon","year":"2022","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2026.210052_bb0315","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1016\/j.josat.2026.210052_bb0320","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1377\/hlthaff.2025.00344","article-title":"Key-informant perspectives on pharmacy-based methadone treatment for opioid use disorder in the US","volume":"44","author":"Stewart","year":"2025","journal-title":"Health Affairs (Project Hope)"},{"key":"10.1016\/j.josat.2026.210052_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108031","article-title":"One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission","volume":"115","author":"Stone","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210052_bb0330","series-title":"Federal Guidelines for Opioid Treatment Programs","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/ADM.0000000000001388","article-title":"Clinician and practice characteristics associated with support of office-based methadone: Findings from a national survey","volume":"19","author":"Sung","year":"2025","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210052_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2021.100082","article-title":"Rural community pharmacist willingness to dispense Suboxone\u00ae\u2014A secret shopper investigation in South-Central Appalachia","volume":"4","author":"Trull","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0345","doi-asserted-by":"crossref","DOI":"10.18553\/jmcp.2022.28.1.85","article-title":"Pharmacists as accessible health care providers: Quantifying the opportunity","volume":"28","author":"Valliant","year":"2022","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0350","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2026.210052_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103591","article-title":"Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations","volume":"102","author":"Welsh","year":"2022","journal-title":"The International Journal on Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2026.210052_bb0360","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/add.15641","article-title":"Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: Results from a feasibility clinical trial","volume":"117","author":"Wu","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2026.210052_bb0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13722-023-00399-6","article-title":"Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: A qualitative study in the U.S","volume":"18","author":"Wu","year":"2023","journal-title":"Addiction Science & Clinical Practice"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T13:29:40Z","timestamp":1786195780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":73,"alternative-id":["S2949875926001724"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210052","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone in community pharmacies: A mixed methods study of board-certified addiction medicine physician and addiction psychiatrist perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210052"}}